A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors with Resectable Disease with Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)
Clinical trial NCT06331598 · WITHDRAWN
Trial details
- NCT number
- NCT06331598
- Sponsor
- Hoffmann-La Roche
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-30
- Primary completion
- 2028-10-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.